Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR)

Gert Klug, Sebastian Reinstadler, Felix Troger, Magdalena Holzknecht, Martin Reindl, Christina Tiller, Ivan Lechner, Priscilla Fink, Mathias Pamminger, Christian Kremser, Hanno Ulmer, Axel Bauer, Bernhard Metzler, Agnes Mayr, Gert Klug, Sebastian Reinstadler, Felix Troger, Magdalena Holzknecht, Martin Reindl, Christina Tiller, Ivan Lechner, Priscilla Fink, Mathias Pamminger, Christian Kremser, Hanno Ulmer, Axel Bauer, Bernhard Metzler, Agnes Mayr

Abstract

Background: The standard procedure for the planning of transcatheter aortic valve replacement (TAVR) is the combination of echocardiography, coronary angiography, and cardiovascular computed tomography (TAVR-CT) for the exact determination of the aortic valve dimensions, valve size, and implantation route. However, up to 80% of the patients undergoing TAVR suffer from chronic renal insufficiency. Alternatives to reduce the need for iodinated contrast agents are desirable. Cardiac magnetic resonance (CMR) imaging recently has emerged as such an alternative. Therefore, we aim to investigate, for the first time, the non-inferiority of TAVR-CMR to TAVR-CT regarding efficacy and safety end-points.

Methods: This is a prospective, randomized, open-label trial. It is planned to include 250 patients with symptomatic severe aortic stenosis scheduled for TAVR based on a local heart-team decision. Patients will be randomized in a 1:1 fashion to receive a predefined TAVR-CMR protocol or to receive a standard TAVR-CT protocol within 2 weeks after inclusion. Follow-up will be performed at hospital discharge after TAVR and after 1 and 2 years. The primary efficacy outcome is device implantation success at discharge. The secondary endpoints are a combined safety endpoint and a combined clinical efficacy endpoint at baseline and at 1 and 2 years, as well as a comparison of imaging procedure related variables. Endpoint definitions are based on the updated 2012 VARC-2 consensus document.

Discussion: TAVR-CMR might be an alternative to TAVR-CT for planning a TAVR procedure. If proven to be effective and safe, a broader application of TAVR-CMR might reduce the incidence of acute kidney injury after TAVR and thus improve outcomes.

Trial registration: The trial is registered at ClinicalTrials.gov (NCT03831087). The results will be disseminated at scientific meetings and publication in peer-reviewed journals.

Keywords: Cardiac magnetic resonance; Computed tomography; Kidney injury; Transcatheter aortic valve replacement.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Study design flow chart. TAVR, transcatheter aortic valve replacement; CMR, cardiovascular magnetic resonance; CT, computed tomography

References

    1. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012) Eur Heart J. 2012;33(19):2451–2496. doi: 10.1093/eurheartj/ehs109.
    1. Otto CM, Pearlman AS. Doppler echocardiography in adults with symptomatic aortic stenosis. Diagnostic utility and cost-effectiveness. Arch Int Med. 1988;148(12):2553–60. doi: 10.1001/archinte.1988.00380120023006.
    1. Brown JM, O'Brien SM, Wu C, Sikora JA, Griffith BP, Gammie JS. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg. 2009;137(1):82–90. doi: 10.1016/j.jtcvs.2008.08.015.
    1. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343(9):611–617. doi: 10.1056/NEJM200008313430903.
    1. Turina J, Hess O, Sepulcri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J. 1987;8(5):471–483. doi: 10.1093/oxfordjournals.eurheartj.a062307.
    1. Kelly TA, Rothbart RM, Cooper CM, Kaiser DL, Smucker ML, Gibson RS. Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis. Am J Cardiol. 1988;61(1):123–130. doi: 10.1016/0002-9149(88)91317-3.
    1. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22):e57–185. doi: 10.1016/j.jacc.2014.02.536.
    1. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi: 10.1056/NEJMoa1103510.
    1. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620. doi: 10.1056/NEJMoa1514616.
    1. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484. doi: 10.1016/S0140-6736(15)60308-7.
    1. Kazmaier T, Köppen M. Aortenklappenchirurgie, isoliert. From: Quality report [Qualitätsreport] 2014, Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen. Göttingen; 2015.
    1. Zamorano JL, Goncalves A, Lang R. Imaging to select and guide transcatheter aortic valve implantation. Eur Heart J. 2014;35(24):1578–1587. doi: 10.1093/eurheartj/eht569.
    1. Barbash IM, Ben-Dor I, Dvir D, Maluenda G, Xue Z, Torguson R, et al. Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement. Am Heart J. 2012;163(6):1031–1036. doi: 10.1016/j.ahj.2012.01.009.
    1. Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol : CJASN. 2008;3(5):1274–1281. doi: 10.2215/CJN.01260308.
    1. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochelliere R, Doyle D, et al. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31(7):865–874. doi: 10.1093/eurheartj/ehp552.
    1. Huber K, Ulmer H, Lang IM, Muhlberger V. Coronary interventions in Austria, Germany, and Switzerland. Eur Heart J. 2020;41(27):2599–2600. doi: 10.1093/eurheartj/ehaa291.
    1. Blaßfeld D. Aortenklappenchirurgie, isoliert. From: Quality report [Qualitätsreport] 2020, Institut für angewandte Qualitätsförderung und Forschung im Gesundheitswesen. Göttingen; 2020.
    1. Thongprayoon C, Cheungpasitporn W, Srivali N, Harrison AM, Gunderson TM, Kittanamongkolchai W, et al. AKI after transcatheter or surgical aortic valve replacement. J Am Soc Nephrol. 2016;27(6):1854–1860. doi: 10.1681/ASN.2015050577.
    1. Thongprayoon C, Cheungpasitporn W, Srivali N, Ungprasert P, Kittanamongkolchai W, Greason KL, et al. Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis. Am J Nephrol. 2015;41(4–5):372–382. doi: 10.1159/000431337.
    1. Chieffo A, Giustino G, Spagnolo P, Panoulas VF, Montorfano M, Latib A, et al. Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2015;8(7):e002025. doi: 10.1161/CIRCINTERVENTIONS.114.002025.
    1. Spagnolo P, Giglio M, Di Marco D, Latib A, Besana F, Chieffo A, et al. Feasibility of ultra-low contrast 64-slice computed tomography angiography before transcatheter aortic valve implantation: a real-world experience. Eur Heart J Cardiovasc Imaging. 2016;17(1):24–33.
    1. La Manna A, Sanfilippo A, Capodanno D, Salemi A, Polizzi G, Deste W, et al. Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study. J Cardiovasc Magn Reson. 2011;13:82. doi: 10.1186/1532-429X-13-82.
    1. Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M, et al. Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiol. 2016;105(3):273–278. doi: 10.1007/s00392-015-0920-6.
    1. Jabbour A, Ismail TF, Moat N, Gulati A, Roussin I, Alpendurada F, et al. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol. 2011;58(21):2165–2173. doi: 10.1016/j.jacc.2011.09.010.
    1. Tsang W, Bateman MG, Weinert L, Pellegrini G, Mor-Avi V, Sugeng L, et al. Accuracy of aortic annular measurements obtained from three-dimensional echocardiography, CT and MRI: human in vitro and in vivo studies. Heart. 2012;98(15):1146–1152. doi: 10.1136/heartjnl-2012-302074.
    1. Koos R, Altiok E, Mahnken AH, Neizel M, Dohmen G, Marx N, et al. Evaluation of aortic root for definition of prosthesis size by magnetic resonance imaging and cardiac computed tomography: implications for transcatheter aortic valve implantation. Int J Cardiol. 2012;158(3):353–358. doi: 10.1016/j.ijcard.2011.01.044.
    1. Ruile P, Blanke P, Krauss T, Dorfs S, Jung B, Jander N, et al. Pre-procedural assessment of aortic annulus dimensions for transcatheter aortic valve replacement: comparison of a non-contrast 3D MRA protocol with contrast-enhanced cardiac dual-source CT angiography. Eur Heart J Cardiovasc Imaging. 2016;17(4):458–466. doi: 10.1093/ehjci/jev188.
    1. Renker M, Varga-Szemes A, Schoepf UJ, Baumann S, Piccini D, Zenge MO, et al. A non-contrast self-navigated 3-dimensional MR technique for aortic root and vascular access route assessment in the context of transcatheter aortic valve replacement: proof of concept. Eur Radiol. 2016;26(4):951–958. doi: 10.1007/s00330-015-3906-x.
    1. Chan JL, Mazilu D, Miller JG, Hunt T, Horvath KA, Li M. Robotic-assisted real-time MRI-guided TAVR: from system deployment to in vivo experiment in swine model. Int J Comput Assist Radiol Surg. 2016;11(10):1905–18. doi: 10.1007/s11548-016-1421-4.
    1. Miller JG, Li M, Mazilu D, Hunt T, Horvath KA. Robot-assisted real-time magnetic resonance image-guided transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2016;151(5):1407–1412. doi: 10.1016/j.jtcvs.2015.11.047.
    1. Quail MA, Nordmeyer J, Schievano S, Reinthaler M, Mullen MJ, Taylor AM. Use of cardiovascular magnetic resonance imaging for TAVR assessment in patients with bioprosthetic aortic valves: comparison with computed tomography. Eur J Radiol. 2012;81(12):3912–3917. doi: 10.1016/j.ejrad.2012.07.014.
    1. Mayr A, Klug G, Reinstadler SJ, Feistritzer HJ, Reindl M, Kremser C, et al. Is MRI equivalent to CT in the guidance of TAVR? A pilot study. Eur Radiol. 2018;28(11):4625–4634. doi: 10.1007/s00330-018-5386-2.
    1. Pamminger M, Klug G, Kranewitter C, Reindl M, Reinstadler SJ, Henninger B, et al. Non-contrast MRI protocol for TAVI guidance: quiescent-interval single-shot angiography in comparison with contrast-enhanced CT. Eur Radiol. 2020;30(9):4847–4856. doi: 10.1007/s00330-020-06832-7.
    1. Pamminger M, Kranewitter C, Kremser C, Reindl M, Reinstadler SJ, Henninger B, et al. Self-navigated versus navigator-gated 3D MRI sequence for non-enhanced aortic root measurement in transcatheter aortic valve implantation. Eur J Radiol. 2021;137:109573. doi: 10.1016/j.ejrad.2021.109573.
    1. Chaturvedi A, Hobbs SK, Ling FS, Knight P. MRI evaluation prior to Transcatheter Aortic Valve Implantation (TAVI): when to acquire and how to interpret. Insights Imaging. 2016;7(2):245–254. doi: 10.1007/s13244-016-0470-0.
    1. Gopal A, Grayburn PA, Mack M, Chacon I, Kim R, Montenegro D, et al. Noncontrast 3D CMR imaging for aortic valve annulus sizing in TAVR. JACC Cardiovasc Imaging. 2015;8(3):375–378. doi: 10.1016/j.jcmg.2014.11.011.
    1. Kappetein AP, Head SJ, Genereux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012;60(15):1438–1454. doi: 10.1016/j.jacc.2012.09.001.
    1. Al Wakeel J, Al Harbi A, Bayoumi M, Al-Suwaida K, Al Ghonaim M, Mishkiry A. Quality of life in hemodialysis and peritoneal dialysis patients in Saudi Arabia. Ann Saudi Med. 2012;32(6):570–574. doi: 10.5144/0256-4947.2012.570.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다